FDA Inspection
Genentech, Inc.Genentech, Inc. – FDA Inspection, Feb 1, 2017
Record Details
This FDA Inspection record concerns Genentech, Inc., with an inspection on February 1, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5f47bb5b-d0eb-4ead-9e52-8cbd30abde99
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1030382
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Genentech, Inc.
34| Date | Classification | Office | Project area |
|---|---|---|---|
| August 4, 2026 | Not classified | San Francisco District Office | |
| May 15, 2026 | Not classified | San Francisco District Office | |
| April 7, 2026 | Not classified | San Francisco District Office | |
| April 21, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 2, 2024 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
Other documents for Genentech, Inc.
- FDA Inspection 1332732 - 2026-08-04
- FDA Inspection 1322404 - 2026-05-15
- FDA Inspection 1314654 - 2026-04-07
- FDA Inspection 1263573 - 2025-04-21
- FDA Inspection 1236964 - 2024-05-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.